Nutrition Testing Explained: CGMs, Micronutrients, Microbiome & Genetics

What this means

Nutrition testing in longevity clinics usually means four products sold as one story: a continuous glucose monitor, a large micronutrient blood or urine panel, a stool microbiome sequence, and a genetic “food” or nutrigenomic report. Only some of those tools have a clear clinical job. The rest often lack clinical validity—a proven link between the result and a decision that improves health.

A CGM estimates glucose in interstitial fluid every few minutes. NIDDK describes real-time, intermittent-scan, and professional (clinic-owned) devices used to manage diabetes, spot highs and lows, and, for some people, reduce fingersticks. FDA authorizations for leading systems are written for diabetes management, including communication with insulin pumps—not for ranking breakfasts in people with a normal A1C.

Micronutrient panels measure vitamins, minerals, and sometimes amino acids or oxidative markers. A few assays are standard when a clinician suspects deficiency—iron studies, vitamin B12, or 25-hydroxyvitamin D in selected patients. A 20- to 40-analyte “optimal wellness” printout is a different product. USPSTF concluded that evidence is insufficient to recommend for or against screening asymptomatic, community-dwelling, nonpregnant adults for vitamin D deficiency. NIH’s Office of Dietary Supplements notes assay variability and that routine screening has not been shown to improve outcomes.

Microbiome and genetic food tests sit further from practice guidelines. Stool sequencing can describe taxa. It does not diagnose a disease or prescribe a supplement stack with the confidence of a validated IVD. FDA regulates in vitro diagnostics used to diagnose or monitor conditions; many wellness kits are marketed around that line. This page is for adults offered a nutrition-testing bundle. It is not a substitute for celiac serology, indicated diabetes testing, or eating-disorder care.

What the evidence shows

CGM evidence is strongest in insulin-treated diabetes. NIDDK explains that sensors estimate glucose in fluid between cells and that some readings still need a meter check when they do not match symptoms or when you change insulin. Professional CGM can help a diabetes clinician review patterns. In people without diabetes, post-meal bumps are expected. Using a spike after fruit to sell restriction or supplements is not the same as ADA or USPSTF glucose diagnosis.

Vitamin D illustrates the micronutrient problem. Total 25-hydroxyvitamin D is the usual status marker, but methods disagree. USPSTF’s screening statement applies to adults without signs of deficiency and without conditions that already warrant treatment. Feeling tired is not, by itself, a reason for an annual 30-test nutrient panel. Targeted testing after history and exam—malabsorption, restrictive diet, bariatric surgery, osteoporosis, or neuropathy—has a clearer rationale.

Direct-to-consumer gut tests were compared in a PMC performance paper: there is no regulatory-approved clinical microbiome diagnostic in the United States, and there is no agreed healthy microbiome to score against. Labs still flag “pathogens,” invent gut-health indexes, and recommend products. NCCIH’s probiotic review is strain- and condition-specific. FDA has not approved probiotic health claims. A colorful diversity score is not a reason to start high-dose organisms in someone who is immunocompromised.

Nutrigenomic panels typically genotype a handful of variants and print diet advice. A PMC overview of DTC nutrition genetics notes that companies often hide which genes they use and that the science is not ready for routine clinical meal plans. Older meta-analytic work on genes sold in commercial tests found no consistent, statistically robust diet-disease links for the marketed set. Known exceptions in medical genetics—such as established hemochromatosis or phenylketonuria pathways—are not what a $200 “carb gene” kit is selling.

• Use when indicated: CGM in diabetes care; targeted nutrient assays after a clinical question.
• Uncertain: wellness CGM in people without diabetes.
• Usually not clinically valid: microbiome wellness scores and grocery-list genotypes.

Common myths

Myth: a CGM spike means that food is unhealthy. In people without diabetes, a rise after a mixed meal is physiology. Patterns that matter in diabetes are time-in-range, hypoglycemia, and A1C—not a single banana.

Myth: if a nutrient is “low-normal” on a boutique range, you need an IV or a stack. Reference intervals and “optimal” bands are not the same. Treating a number without a syndrome can mean unnecessary pills and delayed care for anemia, thyroid disease, or depression.

Myth: your stool report shows leaky gut or a pathogen that explains every symptom. Commercial labels are not stool pathogen panels used in hospitals. NCCIH does not treat a wellness sequence as a diagnosis.

Myth: your genes dictate a unique grocery list. Common variants have small effects. FDA’s IVD framework exists because tests that change care need analytical and clinical performance—not a lifestyle PDF.

How clinics use it

Longevity rooms bundle a two-week CGM, a micronutrient draw, a stool kit, and a cheek swab, then a supplement protocol. The useful version starts with medications, diet pattern, weight change, GI bleeding, and guideline glucose and lipid testing. A registered dietitian plus a physician, NP, or PA can order indicated labs and ignore the rest.

Ask which result would change a medicine, a referral, or a diagnosis this month. Ask whether the CGM is FDA-authorized for your indication or a cash wellness sensor. Ask whether the nutrient lab is CLIA-certified and whether ranges are standard or house “optimal.” Ask if the microbiome or gene report is an FDA-authorized IVD or a wellness product.

Be wary of the closed loop: test, supplement, retest, more supplement. That loop funds the clinic. It is not how NIDDK diabetes technology or USPSTF screening is meant to be used.

Practical takeaway

Keep CGM for diabetes management and selected clinician questions. Keep micronutrient testing targeted. Treat microbiome and food-gene kits as entertainment unless a licensed clinician can name a validated decision. Eat a dietary pattern you can sustain, and use primary care for A1C, blood pressure, and indicated deficiency workups. A printout is not a nutrition diagnosis.